| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2018 | WAT Waters Corp /de/ | Kelly Terrence P | SVP, President Ta Instruments | Sell | 1,312 | $212.52 | $278,826.24 | -20.4% | |
| Mar 9, 2018 | MTD Mettler Toledo International Inc/ | Rauch Waldemar | Head Of Process Analytics | Sell | 3,568 | $616.72 | $2,200,458.64 | -29.4% | |
| Mar 9, 2018 | WAT Waters Corp /de/ | Kuebler Christopher A58 | Director | Sell | 7,084 | $209.10 | $1,481,264.40 | -19.2% | |
| Mar 8, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 32,000 | $3.28 | $104,835.25 | +0.3% | |
| Mar 8, 2018 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 1,628 | $3.76 | $6,121.28 | -0.4% | |
| Mar 8, 2018 | WAT Waters Corp /de/ | Kuebler Christopher A58 | Director | Sell | 416 | $209.00 | $86,944.00 | -2.7% | |
| Mar 7, 2018 | OPK Opko Health, Inc. | Rubin Steven D68 | Executive Vp-administration | Buy | 6,000 | $3.25 | $19,500.00 | +0.1% | |
| Mar 7, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 75,000 | $3.29 | $246,946.49 | +0.2% | |
| Mar 6, 2018 | CRL Charles River Laboratories International, Inc. | Girshick Birgit65 | Corporate Executive VP | Sell | 9,893 | $109.10 | $1,079,342.81 | -1.7% | |
| Mar 6, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 24,008 | $110.00 | $2,640,880.00 | -7.4% | |
| Mar 5, 2018 | IQV Iqvia Holdings Inc. | Evanisko Michael J | Director | Sell | 816 | $100.00 | $81,600.00 | -10.6% | |
| Mar 5, 2018 | RVTY Revvity, Inc. | Wilson Frank Anders | Please See Remarks | Sell | 103,656 | $73.94 | $7,663,966.40 | -37.7% | |
| Mar 5, 2018 | TMO Thermo Fisher Scientific Inc. | Williamson Stephen68 | Sr. VP And CFO | Sell | 2,500 | $204.60 | $511,511.00 | -3.1% | |
| Mar 2, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 364,800 | $2.94 | $1,073,715.84 | +24.2% | |
| Mar 2, 2018 | MTD Mettler Toledo International Inc/ | Heidingsfelder Michael | Head Of Industrial | Sell | 3,000 | $590.39 | $1,771,170.00 | -75.0% | |
| Feb 28, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 4,398 | $108.24 | $476,045.64 | - | |
| Feb 28, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 5,102 | $108.03 | $551,175.88 | - | |
| Feb 28, 2018 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 100 | $108.43 | $10,843.00 | -0.8% | |
| Feb 28, 2018 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 5,240 | $107.90 | $565,413.66 | -1.1% | |
| Feb 28, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 2,102 | $108.47 | $227,995.28 | - | |
| Feb 28, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 3,372 | $107.39 | $362,113.39 | - | |
| Feb 28, 2018 | WAT Waters Corp /de/ | Terricciano David | SVP, Global Operations | Sell | 1,523 | $208.80 | $318,002.40 | -19.4% | |
| Feb 28, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 5,098 | $107.81 | $549,639.41 | - | |
| Feb 28, 2018 | MTD Mettler Toledo International Inc/ | Heidingsfelder Michael | Head Of Industrial | Sell | 1,400 | $630.58 | $882,810.00 | -70.0% | |
| Feb 27, 2018 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman &CEO | Sell | 5,993 | $107.91 | $646,703.09 | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.